Silica is among the most popular nanoparticles. Large-scale production and use have increased the risk of human exposure to silica nanoparticles (SiO2NPs). This study aimed to investigate the toxic effects on the kidney, liver and brain of the SiO2NPs. Twenty eight male Wistar albino rats were divided into four groups (n=7 rats) as control (1 mL/day physiological saline administration for 28 day), 6 nm SiO2NP (6 nm, 150 μg/mL/day for 28 day), 20 nm SiO2NP (20 nm, 150 μg/mL/day for 28 day) and 50 nm SiO2NP (50 nm, 150 μg/mL/day for 28 day) groups. After the last administration, rats were sacrificed and kidney, liver and brain samples were taken for biochemical and histological investigation. In all groups, malondialdehyde (MDA) levels, superoxide dismutase (SOD) and catalase (CAT) activities were measured using the spectrophotometric methods. Ultrastructural changes of tissues were evaluated using transmission electron microscopy. In the kidney tissue, the MDA level significantly increased in the 6 and 50 nm groups, while the similar increase was observed in the 6 nm group of the liver and 20 and 50 nm groups of the brain. SOD activity significantly increased in the 6, 20 and 50 nm groups in brain and kidney tissues, but no significant change was observed in the liver tissue groups. Catalase activity decreased in the kidneys at 6 and 50 nm groups and increased in the 20 and 50 nm groups in liver and brain tissues. Ultrastructurally, kidney and liver tissues had normal morphological features in all groups. Degenerative changes were observed in the nerve fibers and axoplasm of myelinated and unmyelinated nerve fibers in 6 nM, 20 nM and 50 nM SiO2NP groups in the brain. These findings showed that exposure to 6, 20 and 50 nm sizes SiO2 NPs may cause toxic effects in the liver, kidney and brain.
. INTRODUCTION
Nanoparticles have a size ranging from 1 to 100 nm. Nanoparticles can be made of materials of diverse chemical nature, the most common being metals (gold, silver, nickel etc.), metal oxides (titanium dioxide, zinc oxide, silicon dioxide etc.), non-oxide ceramics, polymers, organics, carbon and biomolecules. These particles have numerous field including optics, electronics, and textiles, as well as applications in medicine [2] and pharmacy [3, 4] . Humans have been exposed to various nano-scale materials since birth, and the use of nanomaterials creates another threat to human life. Nanoparticles can enter into the body through inhalation, skin, and digestion. Because of their small size, nanoparticles may pass the barriers of biological systems [5] and may reach the most sensitive organs [6, 7] . The toxic effects of nanoparticles on biological systems substantially depend on the physicochemical characteristics of the materials [8] [9] [10] . Reduction of the size of nanomaterials lead to an exponential increase in the surface area and the more reactive the nanomaterial surface [11] . Additionally, surface charge, surface area and shape plays an important role in toxicity of nanoparticles as it largely defines their interactions with the biological systems [12] . Recent studies suggested toxicities associated with the exposure of biological systems to different nanoparticles may be due to different causes, such as membrane damage [13, 14] , oxidative stress [15, 16] , cytotoxicity [17, 18] genotoxicity [19, 20] . İD İD İD İD İD İD İD Among the nanoparticles produced from different metals, silica nanoparticles (SiO2NPs), because of the favourable properties such as smaller size increased surface-to-volume ratio, a higher surface reactivity, high drug loading efficiency, ease of large-scale synthesis and low cost of NP production have been used in many different area such as mechanical polishing, additives to food, optical imaging, cancer therapy, targeted drug delivery, controlled drug release for genes and proteins [21] [22] [23] . This widespread use of SiO2 nanoparticles in many areas has also led to the search for toxic effects on human and environmental health. Recently, a number of researchers have found SiO2 NPs responsible for toxicity in different organs [24] [25] [26] [27] [28] [29] [30] [31] [32] .
Toxicology studies have suggested that SiO2 NPs can induce adverse effects in the liver, kidney and brain [27, 33, 34] . Since the information about the effects on oxidative stress and ultrastructure of tissues are limited, the present study aimed to evaluate the ability of different sizes SiO2 NPs to induce oxidative stress and ultrastructural changes in the liver, kidney and brain of male albino rats as mammalian model, during subacute treatment.
RESULTS

Nanoparticle characterization
XRD results demonstrated a broad peak at about 2θ=22°, which reveals the amorphous nature of the SiO2NPs. The shape and size of particles were verified by FE-SEM images. FE-SEM imaging of the nanoparticles showed uniform spherical structures with size of about 6, 20 and 50 nm. This result is also confirmed by DLS measurement
Biochemical findings
Among control tissues, MDA level was highest in kidney, whereas liver and brain showed lower amounts (Table 1) . Organ-specific responses were seen when tissues were exposed to SiO2NPs for 28 day. Exposure to 6 nm sized SiO2NPs had no effect on MDA levels in brain tissue, whereas kidney and liver showed a significant increase of by 126 % and 65.7 %, respectively when compared to control group (p<0.05). At the 20 nm sized SiO2NPs exposure was not changed MDA level in kidney and liver (p>0.05) but it was significantly increased in brain by 346.6 % as compared with the control value (p<0.05). A similar upward trend was seen at the 50 nm sized exposure. 50 nm sized SiO2NPs exposure was increased MDA level in kidney, liver and brain by 88.38%, 31.14% and 533.3%, respectively, but the value in liver was not significantly different from the control. In control tissues, the activity of SOD was highest in liver, intermediate in kidney and lowest in brain (table 2). In the kidney tissue, SOD activity increased significantly in 6, 20 and 50 nm groups by 67.58%, 120% and 111.26%, respectively as compared with control value (p<0.05). In the liver, SOD activity did not change at all three groups (p>0.05). In the brain, SOD activity significantly increased in 6, 20 and 50 nm groups (p<0.05) by 48%, 118% and 251%, respectively as compared to control value (p<0.05).
CAT activity showed remarkable differences between the three tissues studied. In control tissues, catalase activity was extremely high in kidney and very low liver and brain (table 3). In kidney CAT activity significantly decreased in 6 and 50 nm groups as compared with control group (p<0.05). There was no significant differences between 20 nm group and other groups (p>0.05). CAT activity decreased in 6, 20 and 50 nm groups by 37%, 8% and 35% respectively. In liver tissue, CAT activity increased in 6, 20 and 50 nm groups by 11.7%, 123.1% and 170%, respectively as compared with control value. These increasing was significant in 20 and 50 nm groups (p<0.05). There was no significant change in 6 nm group (p>0.05). Similarly,
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in the brain, CAT activity increased by 1.53%, 66,7% and 105.9% in 6, 20 and 50 nm, respectively as compared with control group (p<0.05). There was no significant change in 6 nm group (p>0.05). 
Histological findings
Kidney, liver and brain tissue sections of all groups were examined ultrastructurally. In the kidney, the glomerules have normal ultrastructural features in all groups ( Figure 1A , 1B, 1C and 1D). The visceral epithelial cells and foot processes of these cells have normal morphological features. In addition endothelium of the glomerular capillaries and glomerular basement membranes were detected as normal ( Figure 1A , 1B, 1C and 1D). In the brain tissue of control group, neurons, myelinated and unmyelinated nerve fibers, glial cells and perivascular area were found to be normal in structure ( Figure 3A , 3B, 3C and 3D). In the myelin sheath of nerve fibers and axoplasms of myelinated and unmyelinated nerve fibers that have degenerative changes were observed in 6 nm ( Figure 4A , 4B), 20 nm ( Figure 4C , 4D) and 50 nm groups ( Figure 5A , 5B, 5C and 5D). In addition, axonal vacuols of unmyelinated nerve fibers were found in 6 nm, 20 nm and 50 nm groups. The perivascular area was detected as normal in 6 nm and 20 nm groups ( Figure 4A , 4B, 4C and 4D). However, perivascular edema was observed in the 50 nm group ( Figure 5D ). In addition, nuclear and intracytoplasmic vacuols in some neurons were observed in the 50 nm group ( Figure 5C ).
DISCUSSION
In the current study, the effects of 6, 20 and 50 nm sized SiO2 NPs on kidney, liver and brain were investigated by using biochemical and histopathological methods. Our findings indicated that different sizes SiO2 NPs cause oxidative stress in the liver, kidney and brain, and additionally, lead to structural damage in the brain tissue.
Oxidative stress is the result of an imbalance between intracellular production of free radicals and cellular defense mechanisms. The balance between oxidant and antioxidant agents may be impaired by an increase in free radicals or by reducing anti-oxidative substances. Oxidative stress can trigger a number of potentially harmful biochemical reactions [35] . Nanoparticles have been shown to produce reactive oxygen species (ROS) via prooxidant functional groups, active redox cycling and particle-cell interactions [36] . ROS constitute a pool of oxidative species including superoxide anion, hydroxyl radical, hydrogen peroxide, singlet oxygen. The antioxidant defense mechanism is very important in response to ROS toxicity. SOD is the first line of the defense mechanism and scavenges superoxide radicals. CAT are other key enzymes in the antioxidant mechanism. They are responsible in the conversion of H2O2 into H2O and molecular O2. The decomposition product of the polyunsatured fatty acids, MDA, is produced naturally as a result of lipid peroxidation and is often used as an indicator of oxidative damage at the cellular level [37] . In this study, to evaluate oxidative stress MDA level, SOD and CAT activities were measured in samples of tissue. Kidney, liver and brain tissues had different characteristics in response to the different sizes of SiO2 NPs. In the kidney tissue, the MDA level significantly increased in the 6 and 50 nm groups, while the similar increase was observed in the 6 nm group of the liver and 20 and 50 nm groups of the brain. SOD activity significantly increased in the 6, 20 and 50 nm groups in brain and kidney tissues, but no significant change was observed in the liver tissue groups. CAT activity decreased in the kidneys at 6 and 50 nm groups and increased in the 20 and 50 nm groups in liver and brain tissues. In recent years, in vivo and in vitro studies have shown that free oxygen radicals develop in response to SiO2 NPs. Chatteria et al. investigated the mechanisms involved in amorphous silica nanoparticles mediated hepatotoxicity and suggested that the depletion of glutathione metabolism and increase of oxidative stress are among the principal causes of a silicamediated hepatotoxicity [38] . Yu et al. [39] reported that intravenous injection of SiO2 NPs induced hepatic granuloma formation, oxidative damage, and apoptosis. Sadek et al. [40] found that administration of SiNPs, for 15 consecutive days, caused changes in oxidative stress parameters such as malondialdehyde, glutathione reduced, catalase, superoxide dismutase, glutathione reductase, and glutathione peroxidase. In addition, they reported that administration of silica nanoparticles induced changes in liver tissue architecture [40] . Nemmar et al. [27] investigated the acute (24 hours) effects of intraperitoneally administered 50 nm silica nanoparticles (0.25 mg/kg) on systemic toxicity, oxidative stress, inflammation, and DNA damage in the lung, heart, liver, kidney, and brain of mice. They found that lipid peroxidation was significantly increased by silica nanoparticles in the lung, liver, kidney, and brain, but was not changed in the heart [27] . Passagne et al. [41] investigated that the cytotoxicity of nano-SiO2 of different sizes (20 and 100 nm) on two renal proximal tubular cell lines (human HK-2 and porcine LLC-PK(1)) and they found that the 20 and 100 nm nano-SiO2 caused oxidative stress. However, they observed that the toxic effect of 20 nm SiO2 was more powerful. Although many studies have reported that oxidative stress induced by nanoparticles is dependent on the nanoparticle size but no relationship has been observed in this study. Although many studies have reported that oxidative stress induced by nanoparticles was size dependent, in our study it was independent of SiO2 NP size. While SiO2 nanoparticles of 6 and 50 nm size in the kidney produced more oxidative stress, nanoparticles of 20 and 50 nm size were more effective in the brain. It was not possible to mention a more toxic nanoparticle size for the liver. The brain tissue produced more oxidative stress to SiO2 nanoparticles than to kidney and liver tissues. This difference between liver, kidney and brain tissues may be related to the fact that brain tissue is more sensitive to oxidative stress because of its high oxygen consumption, its weak antioxidative ability, and the terminal-differentiation feature of neurons [42] .
In the present study, in addition to oxidative stress, ultrastructural evaluation of liver, kidney and brain tissue was performed. According to our histopathological findings, 6, 20 and 50 nm sized SiO2 nanoparticles did not cause any ultrastructural changes in the kidney and liver but they led to significant structural changes in the brain tissue. The most striking findings the brain tissue was degenerative changes in myelinated and unmyelinated nerve fibers. Some of the studies that report on toxicity of SiO2 nanoparticles in rats or mice show that toxicity in the liver, kidney and brain, while some other studies report that silica NPs have no adverse effect and can be used safely. Shaimaa et al. [43] assessed the effect of different doses and durations of intravenous injections of SiO2 NPs on the hepatic tissue structure of adult male albino rats. They injected with 10 mg/kg and 30 mg/kg SiO2NPs for two and four weeks and evaluated histological, immunohistochemical and ultrastructure changes. They reported that SiO2 NPs injections didn't affect the hepatic lobular organization in any dose or duration but they caused hepatocytes structural changes, hepatic granulomatous inflammatory reaction accompanied by localized fibrosis, being prominent with increasing SiO2 NPs' dose and duration of administration. Vidya and Chitra [44] investigated the effects of 1 nm SiO2NPs at sublethal concentration, 12 mg/L were exposed to the freshwater fish, for 96 h and 60 days. They observed that major hepatic lesions includes loss of normal tissue architecture, segmentation of hepatocytes, vacuolization, spindle shaped nucleus and necrosis. Brain tissue of the treated fish showed degeneration of nerve cells, formation of vacuolization, cerebral edema, necrosis of neurofibrillar region and lesion in choroid plexus. Yu et al. [45] evaluated the acute toxicity at 14 d after intravenous injection of SNPs at 29.5, 103.5 and 177.5 mg/kg in mice. They showed that lymphocytic infiltration, granuloma formation, and hydropic degeneration in liver hepatocytes and macrophage proliferation in the liver by A CD68 immunohistochemistry stain. They didn't observed significant changes in morphology of kidney and brain in the SiNP treated mice. Chan et al. [34] investigated the in vivo toxicity of SiNPs of 150 nm in various dosages via intravenous administration in mice. Blood examinations showed no definite systemic dysfunction of organ systems. Histopathological studies of vital organs confirmed no SiNP-related adverse effects. They concluded that 150 nm SiNPs were biocompatible and safe for in vivo use in mice. Lai et al. [46] investigated the subchronic oral toxicity of silica nanoparticles (NPs) and silica microparticles (MPs) in rats. Their study demonstrated that neither silica NPs nor silica MPs induced toxicological effects after subchronic oral exposure in rats. The sizes, dosage, physiochemical properties and route of entry of the SiO2 nanoparticles used in these studies are different. The controversial results in toxic effects may be related to these differences.
There are some limitations in this study. Firstly, we tested single concentration (150 μg/mL) for the SiO2NPs. It is possible that higher concentration of SiO2NPs may induce oxidative damage that was not detectable in this concentration. The toxic effect of SiO2 NPs could be investigated in a dose-dependent manner. Secondly, ıt was used only the ultrastructural technique to investigare tissue damage. Different techniques such as immunohistochemistry could be used for this.
CONCLUSION
We conclude that subchronic systemic exposure to 6, 20 and 50 nm size and 150 mg/mL SiO2 NPs causes oxidative stress in the liver, kidney and brain. In addition, it causes structural changes in the brain that are compatible with neurotoxicity. The effects of SiO2NPs must be thoroughly investigated before they can be used in humans.
MATERIALS AND METHODS
Nanoparticle preparation and characterization
In this study, 6, 20 and 50 nm diameter SiO2 NPs were used. The SiO2 NPs were prepared according to Stober method (Costa et al.) and characterized according to the procedures reported in the our previous studies [24, 25] . For synthesis, 0.1 mL APTES, 1.2 mL TEOS, 1.2 mL NH4OH and 5 mL ethanol were mixed homogeneously under an inert atmosphere overnight. thereafter, the nanoparticles were washed with absolute ethanol for five times to remove unreacted chemicals. The sizes of nanoparticles were adjusted by changing the precursor concentrations. Advanced X-ray diffractometer (XRD) (Bruker D8), field emissionscanning electron microscopy (FE-SEM) (Zeiss/Supra 55 FE-SEM) and dynamic light scattering (DLS) (Zetasizer Nano ZS) were used for the characterization of SiO2 NPs.
Animals
In the present study, twenty eight healthy adult male Wistar albino rats weighing 180-250 g were used and the rats were housed in stainless steel cages (7 rats per cage) at 24±1.5 °C and 55% humidity level under the 12:12 h day-night cycle. Rats were fed with standard laboratory rat diet and fresh drinking water were provided ad libitum. Experimental protocol was approved by Mersin University Experimental Animals Local Ethics Committee (approval number: 12.04.2016/5260294-050/85248). All experiments were carried out in accordance with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals.
Experimental Design
Twenty eight male Wistar albino rats were equally divided into four groups (n=7 rats) as control (1 mL 0.9% saline per day, intraperitoneally for 28 day), 6 nm SiO2NP (6 nm, 150 μg/mL/day, intraperitoneally for 28 day), 20 nm SiO2NP (20 nm, 150 μg/mL/day, intraperitoneally for 28 day) and 50 nm SiO2NP (50 nm, 150 μg/mL/day, intraperitoneally for 28 day) groups.
T he animals were sacrificed at one day after end administration by cervical dislocation. The liver, kidney and brain samples were excised. These samples were used for biochemical and histological analyses.
Biochemical evaluation
The MDA level was measured in homogenized kidney, liver and brain tissues by the following procedure according to Yagi [47] . Briefly, 50 μL of homogenate were mixed with 100 μL of 8.1 % sodium dodecyl sulfate (SDS), 750 μL of 20 % TCA (pH:3.5) 750 μL of 0.8 % TBA and 350 μL distilled water. The mixtures were incubated in a boling water bath for 30 min. After cooling, 2.5 mL of n-butanol pyridine and 500 μL distilled water were added and mixed. The reaction mixture was centrifuged at 3,500 rpm for 15 min. The absorbance of the supernatant was measured at 532 nm. The MDA levels were expressed as nmol/mg protein. SOD activity was assayed spectrophotometrically in tissue samples according to the method of the Sun et al. [48] . Briefly, supernatant was incubated with xanthine and xanthine oxidase and then nitroblue tetrazolium (NBT) was added. Thereafter, blue formazan was monitored at 560 nm. The activity of SOD was expressed as IU mg −1 protein. Activity of catalase was evaluated based on a previously described method [49] . The decomposition of H2O2 was monitored spectrophotometrically at 240 nm. Specific activity was defined as micromole substrate decomposed per minute per milligram of protein (U/mg protein). Protein concentration in homogenates was determined based on the procedure described by Lowry et al.
[51] using bovine serum albumin as standard. Absorbance of samples was measured by spectrophotometer at 750 nm.
